4.1 Article

First-in-Human, Single- and Multiple-Ascending-Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase Modulator

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos

Mary E. Matyskiela et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Immunology

The Ikaros family in lymphocyte development

Beate Heizmann et al.

CURRENT OPINION IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

Jan Kroenke et al.

SCIENCE (2014)

Article Biotechnology & Applied Microbiology

Polysaccharide-specific B cell responses to vaccination in humans

Ruth Mitchell et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)

Article Immunology

Aiolos promotes TH17 differentiation by directly silencing Il2 expression

Francisco J. Quintana et al.

NATURE IMMUNOLOGY (2012)

Review Biochemistry & Molecular Biology

The Ikaros gene family: Transcriptional regulators of hematopoiesis and immunity

Liza B. John et al.

MOLECULAR IMMUNOLOGY (2011)

Article Hematology

Ikaros regulates neutrophil differentiation

A Dumortier et al.

BLOOD (2003)